Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Profit | $18.0B | $16.9B | $16.6B | $18.1B | $18.3B | $18.4B | $27.6B | $31.2B | $30.8B | $27.1B | $25.5B | $24.6B | $25.9B | $27.3B | $28.8B | $32.7B | $27.9B | $35.1B | $41.9B | $44.0B |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Merck & Co., Inc.'s last 12-month Gross Profit is $47.4B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Merck & Co., Inc.'s Gross Profit growth was 9.7%. The average annual Gross Profit growth rates for Merck & Co., Inc. have been 17.9% over the past three years, 8.0% over the past five years.
Over the last year, Merck & Co., Inc.'s Gross Profit growth was 9.7%, which is higher than industry growth of 0.3%. It indicates that Merck & Co., Inc.'s Gross Profit growth is Good.